Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
[Exogenous evoked potentials in adolesccents with muftiple sclerosis].
Two Different Types of High-frequency Physical Therapy Promote Improvements in the Balance and Mobility of Persons with Multiple Sclerosis.
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro.
Administrative databases for observational studies in multiple sclerosis: power or peril?
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis.
Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
Genetic Variants and Multiple Sclerosis Risk Gene SLC9A9 Expression in Distinct Human Brain Regions.
Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis.
The effects of thrombomodulin and activated protein C on the pathogenesis of multiple sclerosis.
Divided visual attention: A comparison of patients with multiple sclerosis and controls, assessed with an optokinetic nystagmus suppression task.
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis.
Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage.
midamor: Uses, Dosage, Side Effects
Compromised blood-brain barrier permeability: Novel mechanism by which circulating angiotensin II signals sympathoexcitatory centers during hypertension.
Selective and compartmentalized myelin expression of HspB5.
"Impressive results" in stem cell treatment for multiple sclerosis.
Myeloperoxidase: Bridging the gap in neurodegeneration.
Multiple Approaches to Multiple Sclerosis (and Other Demyelinating Diseases).
[Evaluation of white matter myelination in preterm infants using DTI and MRI].
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
"Venous congestion" as a cause of subcortical white matter T2 hypointensity on magnetic resonance images.
Factors affecting return to work after injury or illness: best evidence synthesis of systematic reviews.
Pages
« first
‹ previous
…
777
778
779
780
781
782
783
784
785
…
next ›
last »